Section: Avian Bacteria

Escherichia coli Infections in Chickens: Pathogenesis, Vaccination, and Necrotic Enteritis

Etiology and Classification

Avian pathogenic Escherichia coli (APEC) strains belong to the family Enterobacteriaceae and are Gram-negative, facultative anaerobic rods. APEC are classified into multiple serogroups based on O (somatic), K (capsular), and H (flagellar) antigens, with O1, O2, O18, and O78 being among the most frequently isolated from diseased poultry [1, 2]. These strains possess a distinct set of virulence-associated genes (VAGs) that differentiate them from commensal E. coli isolates. Key virulence factors include fimbrial adhesins (e.g., F1, P, and S fimbriae), iron acquisition systems (e.g., aerobactin, yersiniabactin), and toxins (e.g., hemolysin, cytotoxic necrotizing factor) [1, 3]. The presence of large plasmids, such as pAPEC-1 and pAPEC-2, often carries multiple VAGs and contributes to the pathogenicity of APEC [2].

Epidemiology and Transmission

APEC infections, collectively termed colibacillosis, are a leading cause of morbidity and mortality in commercial poultry worldwide [1, 4]. Transmission occurs horizontally via the fecal-oral route, through contaminated feed, water, litter, and equipment. Vertical transmission through the egg is also documented, though less common [2]. Stressors such as poor ventilation, high stocking density, nutritional deficiencies, and concurrent viral or bacterial infections predispose flocks to colibacillosis [3, 4]. The presence of chicken e coli poop (fecal shedding of APEC) perpetuates environmental contamination and within-flock spread [1]. Young chicks are particularly susceptible during the first two weeks of life due to immature immune defenses [2].

Pathogenesis

APEC pathogenesis is a multifactorial process beginning with colonization of the upper respiratory tract or gastrointestinal mucosa [1, 3]. Following inhalation or ingestion, APEC adhere to epithelial cells via fimbriae and invade the mucosal barrier. The bacteria then enter the bloodstream, leading to bacteremia and systemic dissemination [2]. Iron acquisition systems allow APEC to scavenge iron from host transferrin and hemoglobin, which is critical for survival in the iron-limited host environment [3]. The production of toxins, including hemolysins and cytotoxic necrotizing factor 1, damages host cells and facilitates tissue invasion [1, 4]. Systemic infection results in fibrinous polyserositis, pericarditis, perihepatitis, airsacculitis, and salpingitis [2, 3].

Role in Necrotic Enteritis

Necrotic enteritis (NE) is primarily caused by Clostridium perfringens type A and type C, but APEC can act as a predisposing factor or co-pathogen [4, 5]. Damage to the intestinal mucosa by APEC or other agents (e.g., coccidiosis) creates an anaerobic environment favorable for C. perfringens proliferation [5]. The term chicken necrosis in the context of NE refers to the coagulative necrosis of the intestinal villi, leading to a characteristic "Turkish towel" appearance of the mucosa [4]. APEC may also directly contribute to intestinal inflammation and necrosis through the action of cytotoxic necrotizing factor [1]. Co-infections with APEC and C. perfringens are associated with more severe clinical outcomes and higher mortality [5].

Clinical Signs

Clinical manifestations of colibacillosis vary with the age of the bird and the route of infection [1, 2]. In acute septicemic forms, affected chickens show depression, ruffled feathers, anorexia, fever, and increased mortality [3]. Respiratory signs such as dyspnea, coughing, and rales are common when airsacculitis is present [2]. In laying hens, salpingitis and peritonitis lead to decreased egg production and the presence of misshapen or soft-shelled eggs [1]. Chicken e coli poop may appear as watery, greenish diarrhea due to enteric involvement [3]. In cases of necrotic enteritis, birds exhibit sudden onset of severe depression, diarrhea (often dark or bloody), and rapid death [4, 5].

Pathology

Gross lesions in colibacillosis include fibrinous exudates on the pericardium (pericarditis), liver capsule (perihepatitis), and air sacs (airsacculitis) [1, 2]. The liver may be enlarged and congested, and the spleen may be swollen [3]. In salpingitis, the oviduct is distended with caseous exudate [2]. For necrotic enteritis, the small intestine (particularly the jejunum and ileum) is distended, friable, and contains a foul-smelling, brownish fluid [4, 5]. The mucosal surface shows a thick, diphtheritic membrane composed of necrotic tissue and fibrin, often described as a "Turkish towel" appearance [4]. Histologically, there is severe coagulative necrosis of the villi with massive infiltration of Gram-positive rods (C. perfringens) and Gram-negative rods (APEC) in mixed infections [5].

Diagnostics

Definitive diagnosis of colibacillosis requires isolation and identification of APEC from affected tissues (liver, spleen, heart blood, bone marrow) using selective media such as MacConkey agar [1, 2]. Biochemical confirmation (e.g., indole positive, citrate negative) and serotyping are performed for epidemiological purposes [3]. Molecular detection of VAGs via polymerase chain reaction (PCR) can differentiate APEC from commensal strains [2]. For necrotic enteritis, diagnosis is based on gross and histopathological lesions, anaerobic culture of C. perfringens from intestinal contents, and detection of its toxins (alpha toxin, NetB) by ELISA or PCR [4, 5]. Co-detection of APEC and C. perfringens is recommended in cases of suspected mixed infections [5].

Treatment

Antimicrobial therapy is the mainstay of treatment for colibacillosis, but antibiotic resistance is a growing concern [1, 3]. Commonly used classes include aminopenicillins, tetracyclines, fluoroquinolones, and sulfonamides, with selection guided by culture and sensitivity testing [2]. Supportive care includes improving ventilation, reducing stocking density, and correcting nutritional deficiencies [3]. For necrotic enteritis, treatment involves water-soluble antibiotics effective against C. perfringens, such as bacitracin, lincomycin, or tylosin [4, 5]. Probiotics and organic acids are used as adjuncts to restore gut health [5]. Due to increasing regulatory restrictions on antimicrobial use in poultry, alternative strategies are emphasized [1].

Vaccination

The development of effective e coli chicken vaccine products is a priority for the poultry industry [1, 2]. Autogenous (bacterin) vaccines prepared from farm-specific APEC isolates are commonly used in breeder flocks to provide passive immunity to progeny via maternal antibodies [3]. Commercial vaccines based on inactivated whole cells or subunit antigens (e.g., FimH, IroN) are also available [2]. Live attenuated vaccines, including aroA mutants, have shown promise in experimental settings [1]. Vaccination strategies aim to reduce the incidence of colibacillosis and its complications, including necrotic enteritis [4]. However, vaccine efficacy is often serogroup-specific, and cross-protection remains limited [3].

Control and Prevention

Integrated control measures are essential to reduce APEC burden [1, 2]. Biosecurity protocols include all-in/all-out management, thorough cleaning and disinfection between flocks, and control of rodents and wild birds [3]. Optimizing environmental conditions (temperature, humidity, ammonia levels) minimizes stress [2]. Nutritional interventions such as the use of prebiotics, probiotics, and organic acids can modulate gut microbiota and reduce APEC colonization [4]. For necrotic enteritis prevention, dietary strategies include the use of ionophore anticoccidials, which indirectly control C. perfringens by reducing intestinal mucosal damage from coccidia [5]. Vaccination against coccidiosis and APEC is also part of an integrated program [4].

Mermaid Diagram: Diagnostic and Control Workflow for APEC and Necrotic Enteritis

flowchart TD
    A[Clinical signs: depression, diarrhea, respiratory distress], > B[Postmortem examination]
    B, > C{Gross lesions}
    C, >|Fibrinous polyserositis| D[Colibacillosis suspect]
    C, >|Necrotic enteritis lesions| E[Necrotic enteritis suspect]
    D, > F[Sample: liver, spleen, heart blood]
    F, > G[Culture on MacConkey agar]
    G, > H[Biochemical & serological ID]
    H, > I[PCR for VAGs]
    I, > J[APEC confirmed]
    E, > K[Sample: intestinal contents, mucosa]
    K, > L[Anaerobic culture & toxin detection]
    L, > M[C. perfringens confirmed]
    J, > N[Antimicrobial sensitivity testing]
    N, > O[Targeted antibiotic therapy]
    M, > P[Antibiotics vs C. perfringens + gut health support]
    O, > Q[Vaccination & biosecurity review]
    P, > Q
    Q, > R[Prevention: autogenous vaccine, probiotics, management]

References

[1] Barnes, H.J., Nolan, L.K., and Vaillancourt, J.P. Colibacillosis. In: Swayne, D.E., editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 751-805.

[2] Nolan, L.K., Barnes, H.J., Vaillancourt, J.P., Abdul-Aziz, T., and Logue, C.M. Colibacillosis. In: Swayne, D.E., editor. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013. p. 751-805.

[3] Merck Veterinary Manual. Colibacillosis in Poultry. Kenilworth, NJ: Merck & Co.; 2023. Available at: https://www.merckvetmanual.com/poultry/colibacillosis/colibacillosis-in-poultry.

[4] Cooper, K.K. and Songer, J.G. Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe. 2009;15(1-2):55-60.

[5] Van Immerseel, F., De Buck, J., Pasmans, F., Huyghebaert, G., Haesebrouck, F., and Ducatelle, R. Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathology. 2004;33(6):537-549. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.